- Home
- MED vs FLC Comparison
MED vs FLC Comparison
Compare MED & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- FLC
- Stock Information
- Founded
- MED 1980
- FLC 2003
- Country
- MED United States
- FLC United States
- Employees
- MED N/A
- FLC N/A
- Industry
- MED Packaged Foods
- FLC Trusts Except Educational Religious and Charitable
- Sector
- MED Consumer Staples
- FLC Finance
- Exchange
- MED Nasdaq
- FLC Nasdaq
- Market Cap
- MED 187.3M
- FLC 176.2M
- IPO Year
- MED N/A
- FLC N/A
- Fundamental
- Price
- MED $15.76
- FLC $17.01
- Analyst Decision
- MED Hold
- FLC
- Analyst Count
- MED 1
- FLC 0
- Target Price
- MED $17.00
- FLC N/A
- AVG Volume (30 Days)
- MED 223.4K
- FLC 37.8K
- Earning Date
- MED 02-18-2025
- FLC 01-01-0001
- Dividend Yield
- MED N/A
- FLC 6.64%
- EPS Growth
- MED N/A
- FLC N/A
- EPS
- MED 0.67
- FLC N/A
- Revenue
- MED $674,475,000.00
- FLC N/A
- Revenue This Year
- MED N/A
- FLC N/A
- Revenue Next Year
- MED N/A
- FLC N/A
- P/E Ratio
- MED $23.68
- FLC N/A
- Revenue Growth
- MED N/A
- FLC N/A
- 52 Week Low
- MED $14.94
- FLC $12.62
- 52 Week High
- MED $57.41
- FLC $15.45
- Technical
- Relative Strength Index (RSI)
- MED 39.99
- FLC 58.36
- Support Level
- MED $15.22
- FLC $16.87
- Resistance Level
- MED $15.93
- FLC $17.08
- Average True Range (ATR)
- MED 0.71
- FLC 0.20
- MACD
- MED 0.03
- FLC 0.04
- Stochastic Oscillator
- MED 28.47
- FLC 88.71
About MED MEDIFAST INC
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
About FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.